10-Year Outcomes After Monitoring, Surgery, Or Radiotherapy For Localized Prostate Cancer

·2016·DOI
Health Sciences and Innovation
Biomedical Engineering
Cancer Research and Treatment
Prostate Cancer Treatment Methods

Role in the Field

Neutralin Health Sciences and Innovation
Neutralin Biomedical Engineering
Neutralin Cancer Research and Treatment
Neutralin Prostate Cancer Treatment Methods

Abstract

Citations

2,114

Year

2016

PageRank

4.0 / 10

Relative influence (log-scaled)

Related Papers

11 of 11 papers

Enzalutamide In Metastatic Prostate Cancer Before Chemotherapy
·2014·2,474 citations
Abiraterone In Metastatic Prostate Cancer Without Previous Chemotherapy
·2013·2,461 citations
Abiraterone And Increased Survival In Metastatic Prostate Cancer
·2011·3,845 citations
Sipuleucel-T Immunotherapy For Castration-Resistant Prostate Cancer
·2010·4,831 citations
Prednisone Plus Cabazitaxel Or Mitoxantrone For Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel Treatment: A Randomised Open-Label Trial.
·2010·2,533 citations
Screening And Prostate-Cancer Mortality In A Randomized European Study
·2009·3,503 citations
Docetaxel And Estramustine Compared With Mitoxantrone And Prednisone For Advanced Refractory Prostate Cancer
·2004·3,383 citations
The Influence Of Finasteride On The Development Of Prostate Cancer
·2003·2,446 citations
Natural History Of Progression After PSA Elevation Following Radical Prostatectomy
·1999·2,973 citations
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, Or Interstitial Radiation Therapy For Clinically Localized Prostate Cancer
·1998·4,102 citations
Measurement Of Prostate-Specific Antigen In Serum As A Screening Test For Prostate Cancer
·1991·2,434 citations